HG-1091

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1091

Drug Alias NameA-152E5.1 modulator (Human Genome Sciences)CCL22 modulator (Human Genome Sciences)DC/B-CK modulator (Human Genome Sciences)MGC34554 modulator (Human Genome Sciences)SCYA22 modulator (Human Genome Sciences) +[14]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-C motif chemokine 22 modulators

TargetsC-C motif chemokine 22

Therapy Area/IndicationsInflammationImmune System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A